logo

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Cyclerion Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $9.47 on 12/04/24 and a low of $1.27 for the same time frame on 11/22/24.

52-week price history of CYCN Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cyclerion Therapeutics Inc’s current trading price is -43.82% away from its 52-week high, while its distance from the 52-week low is 318.90%. The stock’s price range during the 52-week period has remained between $1.27 and $9.47. In the Healthcare sector, the company’s shares saw a trading volume of around 29.34 million for the day, which was evidently higher than the average daily volume of 4.6 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Cyclerion Therapeutics Inc (CYCN) has experienced a quarterly rise of 77.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.41M and boasts a workforce of 1 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.86, with a change in price of +2.22. Similarly, Cyclerion Therapeutics Inc recorded 3,105,418 in trading volume during the last 100 days, posting a change of +71.62%.

Examining CYCN’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CYCN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

CYCN Stock Stochastic Average

As of today, Cyclerion Therapeutics Inc’s raw stochastic average for the last 50 days stands at 49.39%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 76.46%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 57.04% and 33.73%, respectively.

CYCN Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 65.22%. However, over the past six months, we’ve seen a weaker performance of 56.70%. The price of CYCN fallen by 65.22% over the last 30 days. And in the last five days, it has surged by 96.31%.

Most Popular